The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor ...

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: those to the acetylcholine receptor (AChR ...

Infinimmune’s AI Model GLIMPSE-1 Engineers Human-Sourced Antibodies The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...

A man spent 18 years injecting himself with venom, almost dying more than once – and now his blood is behind a new snakebite treatment.

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components ...

Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, offering a dual-targeting strategy to enhance the therapeutic efficacy of monoclonal antibodies, which is often limited by ...

Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles.

Engineering antibodies with a novel fusion protein Fusing two immune system proteins leads to a new method of generating antibodies, opening opportunities for advancing drug discovery Date: March ...

Monoclonal antibodies are a type of synthetic, human-made, antibody. They work similarly to antibodies that the body naturally produces, binding only to specific antigens.

The cells were washed two times with cold PBS containing 1% SVF and 0.01% NaN 3 and incubated with anti-histidine-PE (R&D Systems, Minneapolis, MN, USA) or anti-histidine–APC antibody (Miltenyi ...